Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113


Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism.

Henneicke H, Herrmann M, Kalak R, Brennan-Speranza TC, Heinevetter U, Bertollo N, Day RE, Huscher D, Buttgereit F, Dunstan CR, Seibel MJ, Zhou H.

Bone. 2011 Oct;49(4):733-42. doi: 10.1016/j.bone.2011.06.013. Epub 2011 Jun 22.


Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice.

Kalak R, Zhou H, Street J, Day RE, Modzelewski JR, Spies CM, Liu PY, Li G, Dunstan CR, Seibel MJ.

Bone. 2009 Jul;45(1):61-7. doi: 10.1016/j.bone.2009.03.673. Epub 2009 Apr 7.


Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.

Pantschenko AG, Zhang W, Nahounou M, McCarthy MB, Stover ML, Lichtler AC, Clark SH, Gronowicz GA.

J Bone Miner Res. 2005 Aug;20(8):1414-29. Epub 2005 Mar 14.


Chronic Mild Stress Causes Bone Loss via an Osteoblast-Specific Glucocorticoid-Dependent Mechanism.

Henneicke H, Li J, Kim S, Gasparini SJ, Seibel MJ, Zhou H.

Endocrinology. 2017 Jun 1;158(6):1939-1950. doi: 10.1210/en.2016-1658.


A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.

Khan MP, Mishra JS, Sharan K, Yadav M, Singh AK, Srivastava A, Kumar S, Bhaduaria S, Maurya R, Sanyal S, Chattopadhyay N.

Phytomedicine. 2013 Nov 15;20(14):1256-66. doi: 10.1016/j.phymed.2013.07.007. Epub 2013 Aug 6.


Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.

Iida-Klein A, Zhou H, Lu SS, Levine LR, Ducayen-Knowles M, Dempster DW, Nieves J, Lindsay R.

J Bone Miner Res. 2002 May;17(5):808-16.


Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo.

Buttgereit F, Zhou H, Kalak R, Gaber T, Spies CM, Huscher D, Straub RH, Modzelewski J, Dunstan CR, Seibel MJ.

Arthritis Rheum. 2009 Jul;60(7):1998-2007. doi: 10.1002/art.24619.


The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.

Oxlund H, Ortoft G, Thomsen JS, Danielsen CC, Ejersted C, Andreassen TT.

Bone. 2006 Aug;39(2):244-52. Epub 2006 Feb 28.


Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice.

Silha JV, Mishra S, Rosen CJ, Beamer WG, Turner RT, Powell DR, Murphy LJ.

J Bone Miner Res. 2003 Oct;18(10):1834-41.


Transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone.

Sher LB, Woitge HW, Adams DJ, Gronowicz GA, Krozowski Z, Harrison JR, Kream BE.

Endocrinology. 2004 Feb;145(2):922-9. Epub 2003 Nov 14.


Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide.

Kondo E, Yasoda A, Fujii T, Nakao K, Yamashita Y, Ueda-Sakane Y, Kanamoto N, Miura M, Arai H, Mukoyama M, Inagaki N, Nakao K.

Endocrinology. 2015 Jul;156(7):2518-29. doi: 10.1210/en.2014-1801. Epub 2015 Apr 10.


Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.

Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S.

J Bone Miner Res. 2007 Jun;22(6):849-59.


Mechanisms of bone fragility in a mouse model of glucocorticoid-treated rheumatoid arthritis: implications for insufficiency fracture risk.

Takahata M, Maher JR, Juneja SC, Inzana J, Xing L, Schwarz EM, Berger AJ, Awad HA.

Arthritis Rheum. 2012 Nov;64(11):3649-59. doi: 10.1002/art.34639.


Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption.

Peng S, Liu XS, Zhou G, Li Z, Luk KD, Guo XE, Lu WW.

J Bone Miner Res. 2011 Jun;26(6):1272-82. doi: 10.1002/jbmr.325.


Anabolic effect of prostaglandin E2 on cortical bone of aged male rats comes mainly from modeling-dependent bone gain.

Yao W, Jee WS, Zhou H, Lu J, Cui L, Setterberg R, Liang T, Ma Y.

Bone. 1999 Dec;25(6):697-702.


Chronic alcohol consumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength.

Wezeman FH, Emanuele MA, Emanuele NV, Moskal SF 2nd, Woods M, Suri M, Steiner J, LaPaglia N.

Alcohol Clin Exp Res. 1999 Sep;23(9):1534-42.


Epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo.

Zhang X, Tamasi J, Lu X, Zhu J, Chen H, Tian X, Lee TC, Threadgill DW, Kream BE, Kang Y, Partridge NC, Qin L.

J Bone Miner Res. 2011 May;26(5):1022-34. doi: 10.1002/jbmr.295.


Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.

Yang M, Trettel LB, Adams DJ, Harrison JR, Canalis E, Kream BE.

Bone. 2010 Sep;47(3):573-82. doi: 10.1016/j.bone.2010.06.002. Epub 2010 Jun 9.


Longitudinal in vivo effects of growth hormone overexpression on bone in transgenic mice.

Eckstein F, Weusten A, Schmidt C, Wehr U, Wanke R, Rambeck W, Wolf E, Mohan S.

J Bone Miner Res. 2004 May;19(5):802-10. Epub 2004 Mar 15.


Overexpression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice.

Valverde P, Zhang J, Fix A, Zhu J, Ma W, Tu Q, Chen J.

J Bone Miner Res. 2008 Nov;23(11):1775-88. doi: 10.1359/jbmr.080605.

Supplemental Content

Support Center